WHO-ATC class | ADRs, n | % all ADRs | |
---|---|---|---|
A | Alimentary tract and metabolism | 18 | 8.53 |
A02 | Drugs for acid-related disorders | 10 | 4.74 |
A07 | Antidiarrhoeal, intestinal anti-inflammatory/anti-infective agents | 1 | 0.47 |
A10 | Drugs used in diabetes | 5 | 2.37 |
A11 | Vitamins | 1 | 0.47 |
A12 | Mineral supplements | 1 | 0.47 |
B | Blood and blood forming organs | 4 | 1.90 |
B01 | Antithrombotic agents | 3 | 1.42 |
B03 | Antianaemic preparations | 1 | 0.47 |
C | Cardiovascular system | 69 | 32.70 |
C01 | Cardiac therapy | 5 | 2.37 |
C02 | Antihypertensives | 2 | 0.95 |
C03 | Diuretics | 13 | 6.16 |
C07 | Beta blocking agents | 4 | 1.90 |
C08 | Calcium channel blockers | 17 | 8.06 |
C09 | Agents acting on the renin-angiotensin system | 19 | 9.00 |
C10 | Lipid-modifying agents | 9 | 4.27 |
G | Genito-urinary system and sex hormones | 10 | 4.74 |
G04 | Urologicals | 10 | 4.74 |
H | Systemic hormonal preparations, excluding sex hormones and insulins | 4 | 1.90 |
H03 | Thyroid therapy | 3 | 1.42 |
H05 | Calcium homeostasis | 1 | 0.47 |
J | Anti-infectives for systemic use | 26 | 12.32 |
J01 | Antibacterials for systemic use | 26 | 12.32 |
L | Antineoplastic and immunomodulating agents | 1 | 0.47 |
L04 | Immunosuppressants | 1 | 0.47 |
M | Musculoskeletal system | 14 | 6.64 |
M01 | Anti-inflammatory and antirheumatic products | 10 | 4.74 |
M05 | Drugs for treatment of bone diseases | 4 | 1.90 |
N | Nervous system | 61 | 28.91 |
N01 | Anaesthetics | 4 | 1.90 |
N02 | Analgesics | 28 | 13.27 |
N03 | Antiepileptics | 7 | 3.32 |
N04 | Anti-Parkinson’s drugs | 1 | 0.47 |
N05 | Psycholeptics | 4 | 1.90 |
N06 | Psychoanaleptics | 16 | 7.58 |
N07 | Other nervous system drugs | 1 | 0.47 |
R | Respiratory system | 4 | 1.90 |
R03 | Drugs for obstructive airway diseases | 2 | 0.95 |
R06 | Cough and cold preparations | 2 | 0.95 |
ADR = adverse drug reaction. WHO-ATC = World Health Organization Anatomical Therapeutic Code.